Sunitinib in Advanced Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single Institution Retrospective Study
Chiara Paglino, Camillo Porta(University of Pavia), Cristina Bregant(University of Pavia), Ilaria Imarisio(University of Pavia), Alessandro Vercelli(Neuroscience Institute), Patrizia Morbini(University of Pavia), Carlo Ganini
Cited by 16
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Distinct Profiles of Myelin Distribution Along Single Axons of Pyramidal Neurons in the Neocortex
|Science|2014|600
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2012|275